The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

GSK has escalated a dispute over rights to its cancer immunotherapy Jemperli, after its subsidiary Tesaro filed a complaint ...

Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and ...

Now in its 7th year, our free-to-attend careers event will be held at the Royal Society of Medicine on the 18th February 2026 ...

At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix, an emerging, clinical-stage biotech company ...

Personalised cell therapy developer Aspen Neuroscience added $115 million to its cash reserves with a Series C that included ...

The ruling by reimbursement authority NICE means that Amvuttra (vutrisiran) can be used to treat wild-type or hereditary ATTR ...

As part of the 2024 VPAG, there was an agreement to conduct operational review meetings every six months. The first ...

At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story of ...

A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted directly into the cortex of the brain – achieves an information transfer rate ...

Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...